Fierce Biotech News & Reports

Biogen is remaking its pipeline with an ‘entrepreneurial spirit’

Executives told Fierce that the company is in the middle of a transition to “the new Biogen,” which involves embracing partnerships and external investments.

Will Maddox Jun 16, 2026 8:50am

FDA appears less prickly toward Moderna mRNA flu shot

Jun 16, 2026 2:46pm

How NEC's AI and oral delivery system are redefining personalized cancer therapy

Brought to you by NEC Bio

Horseshoe magnet attracting metallic pawn people

Lilly buys 4E to beef up its non-opioid pain pipeline

Jun 16, 2026 2:34pm

MA strategy deal block push come together form

Altaris scoops up AI drug development outfit for $375M

Jun 16, 2026 12:13pm

Heart and stethoscope isolated on blue background concept for healthcare and diagnosis medical cardiac pulse test

Edgewise data power rival to BMS and Cytokinetics toward phase 3

Jun 16, 2026 10:39am

More News

Merck inks $510M biobucks data partnership with Protillion

Jun 16, 2026 10:06am

Fierce Biotech Layoff Tracker 2026: Genentech, Fulcrum & more

Jun 16, 2026 9:45am

Adaptive plots split of drug discovery and diagnostics arms

Jun 16, 2026 9:24am

Spyre bolsters ulcerative colitis ambitions with ph. 2 win

Jun 15, 2026 3:19pm

See more stories